Impact Factor 4.259 | CiteScore 4.30
More on impact ›

Correction ARTICLE

Front. Microbiol., 05 November 2019 | https://doi.org/10.3389/fmicb.2019.02517

Corrigendum: A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis

  • 1School of Pharmaceutical Sciences, Universidade Estadual Paulista, Araraquara, Brazil
  • 2Department of Chemistry, Universidade Federal de São Carlos, São Carlos, Brazil
  • 3Environmental Studies Center, Universidade Estadual Paulista, Rio Claro, Brazil
  • 4Department of Clinical Analysis and Biomedicine, State University of Maringa, Maringá, Brazil

A Corrigendum on
A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis

by da Silva, P. B., de Freitas, E. S., Solcia, M. C., de Souza, P. C., da Silva, M. M., Batista, A. A., et al. (2018). Front. Microbiol. 9:2930. doi: 10.3389/fmicb.2018.02930

In the original article, we neglected to include the funder Grant # 2018/00163-0 São Paulo Research Foundation (FAPESP), to for all authors.

The FUNDING is: “This research was funded by grant #2013/14957-5, grant #2013/09265-7 and grant #2018/00163-0 São Paulo Research Foundation (FAPESP) by the Coordination for the Improvement of Higher Education Personnel (CAPES) together with the Post-Doctoral National Program (PNPD), the Programa de Apoio ao Desenvolvimento Científico (PADC) of School of Pharmaceutical Sciences/UNESP, Brazil and the authors thank UNESP for the data of the dissertation (Freitas, 2015).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

References

Freitas, E. S. (2015). Nanoencapsulação De Compostos De Rutênio, Análise De Sua Atividade Anti-Mycobacterium Tuberculosis E Biodisponibilidade Oral. Ph.D. thesis, São Paulo State University, São Paulo.

Google Scholar

Keywords: ruthenium(II) complexes, tuberculosis, nanotechnology, oral bioavailability, ICP-MS

Citation: da Silva PB, de Freitas ES, Solcia MC, de Souza PC, da Silva MM, Batista AA, Eismann CE, Rolisola AMCM, Menegário AA, Cardoso RF, Chorilli M and Pavan FR (2019) Corrigendum: A Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis. Front. Microbiol. 10:2517. doi: 10.3389/fmicb.2019.02517

Received: 17 October 2019; Accepted: 18 October 2019;
Published: 05 November 2019.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2019 da Silva, de Freitas, Solcia, de Souza, da Silva, Batista, Eismann, Rolisola, Menegário, Cardoso, Chorilli and Pavan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Patricia B. da Silva, patrbent@yahoo.com.br; Fernando R. Pavan, fernando.pavan@unesp.br; pavanunesp@gmail.com